Skip to main navigation Skip to search Skip to main content

Chronic hepatitis B: past, present, and future

  • Michelle Lai*
  • , Yun Fan Liaw
  • *Corresponding author for this work
  • Harvard University

Research output: Contribution to journal › Review article › peer-review

25 Scopus citations

Abstract

There have been major advances in the field of hepatitis B (HBV) over the last few decades. These advances have resulted in the understanding of the natural history of chronic HBV infection, effective vaccines against the virus, sensitive assays for screening and monitoring of treatment, and effective treatments for viral suppression, all leading to improved outcomes. Debates and controversies remain, however, over the ideal management strategies of patients with chronic hepatitis B. To eradicate HBV, the global community needs to improve current preventive, screening, and treatment strategies.

Original languageEnglish
Pages (from-to)531-546
Number of pages16
JournalClinics in Liver Disease
Volume14
Issue number3
DOIs
StatePublished - 08 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Hepatitis B virus
  • Screening
  • Vaccine

Fingerprint

Dive into the research topics of 'Chronic hepatitis B: past, present, and future'. Together they form a unique fingerprint.

Cite this